Generics BRIC (Brazil, Russia, India, China) Industry Guide 2015-2024
Generics BRIC (Brazil, Russia, India, China) Industry Guide 2015-2024
SUMMARY
The BRIC Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
SUMMARY
The BRIC Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
- Brazil, Russian Federation, India and China (BRIC) are the emerging and fast growing countries within the generics industry and had a total market value of $101,698.1 million in 2019. Russia was the fastest growing country with a CAGR of 11.8% over the 2015-19 period.
- Within the generics industry, China is the leading country among the BRIC nations with market revenues of $69,811.0 million in 2019. This was followed by India, Russia and Brazil with a value of $16,448.5, $9,127.7, and $6,310.9 million, respectively.
- China is expected to lead the generics industry in the BRIC nations with a value of $89,577.3 million in 2024, followed by India, Russia, Brazil with expected values of $23,292.4, $11,252.0 and $8,175.3 million, respectively.
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the BRIC generics market
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the BRIC generics market
- Leading company profiles reveal details of key generics market players’ BRIC operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the BRIC generics market with five year forecasts by both value and volume
- Compares data from Brazil, Russia, India, and China, alongside individual chapters on each country
- What was the size of the BRIC generics market by value in 2019?
- What will be the size of the BRIC generics market in 2024?
- What factors are affecting the strength of competition in the BRIC generics market?
- How has the market performed over the last five years?
- How large is the BRIC generics market in relation to its regional counterparts?
1 INTRODUCTION
1.1. What is this report about?
1.2. Who is the target reader?
1.3. How to use this report
1.4. Definitions
2 BRIC GENERICS
2.1. Industry Outlook
3 GENERICS IN BRAZIL
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis
3.6. Macroeconomic Indicators
4 GENERICS IN CHINA
4.1. Market Overview
4.2. Market Data
4.3. Market Segmentation
4.4. Market outlook
4.5. Five forces analysis
4.6. Macroeconomic Indicators
5 GENERICS IN INDIA
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis
5.6. Macroeconomic Indicators
6 GENERICS IN RUSSIA
6.1. Market Overview
6.2. Market Data
6.3. Market Segmentation
6.4. Market outlook
6.5. Five forces analysis
6.6. Macroeconomic Indicators
7 COMPANY PROFILES
7.1. Sanofi SA
7.2. EMS SA
7.3. Ache Laboratorios Farmaceuticos SA
7.4. Eurofarma Laboratorios SA
7.5. Teva Pharmaceutical Industries Limited
7.6. Mylan N.V.
7.7. China Grand Pharmaceutical and Healthcare Holdings Limited
7.8. Pfizer Inc.
7.9. Sun Pharmaceutical Industries Ltd
7.10. Lupin Ltd
7.11. Aurobindo Pharma Ltd
7.12. Cipla Limited
7.13. Krka, d. d., Novo mesto
7.14. Abbott Laboratories
8 APPENDIX
8.1. Methodology
8.2. About MarketLine
1.1. What is this report about?
1.2. Who is the target reader?
1.3. How to use this report
1.4. Definitions
2 BRIC GENERICS
2.1. Industry Outlook
3 GENERICS IN BRAZIL
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis
3.6. Macroeconomic Indicators
4 GENERICS IN CHINA
4.1. Market Overview
4.2. Market Data
4.3. Market Segmentation
4.4. Market outlook
4.5. Five forces analysis
4.6. Macroeconomic Indicators
5 GENERICS IN INDIA
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis
5.6. Macroeconomic Indicators
6 GENERICS IN RUSSIA
6.1. Market Overview
6.2. Market Data
6.3. Market Segmentation
6.4. Market outlook
6.5. Five forces analysis
6.6. Macroeconomic Indicators
7 COMPANY PROFILES
7.1. Sanofi SA
7.2. EMS SA
7.3. Ache Laboratorios Farmaceuticos SA
7.4. Eurofarma Laboratorios SA
7.5. Teva Pharmaceutical Industries Limited
7.6. Mylan N.V.
7.7. China Grand Pharmaceutical and Healthcare Holdings Limited
7.8. Pfizer Inc.
7.9. Sun Pharmaceutical Industries Ltd
7.10. Lupin Ltd
7.11. Aurobindo Pharma Ltd
7.12. Cipla Limited
7.13. Krka, d. d., Novo mesto
7.14. Abbott Laboratories
8 APPENDIX
8.1. Methodology
8.2. About MarketLine
LIST OF TABLES
Table 1: BRIC generics industry, revenue($m), 2015-24
Table 2: BRIC generics industry, revenue($m), 2015-19
Table 3: BRIC generics industry, revenue($m), 2019-24
Table 4: Brazil generics market value: $ million, 2015–19
Table 5: Brazil generics market volume: % of total pharma, 2015–19
Table 6: Brazil generics market geography segmentation: $ million, 2019
Table 7: Brazil generics market value forecast: $ million, 2019–24
Table 8: Brazil generics market volume forecast: % of total pharma, 2019–24
Table 9: Brazil size of population (million), 2015–19
Table 10: Brazil gdp (constant 2005 prices, $ billion), 2015–19
Table 11: Brazil gdp (current prices, $ billion), 2015–19
Table 12: Brazil inflation, 2015–19
Table 13: Brazil consumer price index (absolute), 2015–19
Table 14: Brazil exchange rate, 2015–19
Table 15: China generics market value: $ billion, 2015–19
Table 16: China generics market volume: % of total pharma, 2015–19
Table 17: China generics market geography segmentation: $ billion, 2019
Table 18: China generics market value forecast: $ billion, 2019–24
Table 19: China generics market volume forecast: % of total pharma, 2019–24
Table 20: China size of population (million), 2015–19
Table 21: China gdp (constant 2005 prices, $ billion), 2015–19
Table 22: China gdp (current prices, $ billion), 2015–19
Table 23: China inflation, 2015–19
Table 24: China consumer price index (absolute), 2015–19
Table 25: China exchange rate, 2015–19
Table 26: India generics market value: $ billion, 2015–19
Table 27: India generics market volume: % of total pharma, 2015–19
Table 28: India generics market geography segmentation: $ billion, 2019
Table 29: India generics market value forecast: $ billion, 2019–24
Table 30: India generics market volume forecast: % of total pharma, 2019–24
Table 31: India size of population (million), 2015–19
Table 32: India gdp (constant 2005 prices, $ billion), 2015–19
Table 33: India gdp (current prices, $ billion), 2015–19
Table 34: India inflation, 2015–19
Table 35: India consumer price index (absolute), 2015–19
Table 36: India exchange rate, 2015–19
Table 37: Russia generics market value: $ billion, 2015–19
Table 38: Russia generics market volume: % of total pharma, 2015–19
Table 39: Russia generics market geography segmentation: $ billion, 2019
Table 40: Russia generics market value forecast: $ billion, 2019–24
Table 41: Russia generics market volume forecast: % of total pharma, 2019–24
Table 42: Russia size of population (million), 2015–19
Table 43: Russia gdp (constant 2005 prices, $ billion), 2015–19
Table 44: Russia gdp (current prices, $ billion), 2015–19
Table 45: Russia inflation, 2015–19
Table 46: Russia consumer price index (absolute), 2015–19
Table 47: Russia exchange rate, 2015–19
Table 48: Sanofi SA: key facts
Table 49: Sanofi SA: Annual Financial Ratios
Table 50: Sanofi SA: Key Employees
Table 1: BRIC generics industry, revenue($m), 2015-24
Table 2: BRIC generics industry, revenue($m), 2015-19
Table 3: BRIC generics industry, revenue($m), 2019-24
Table 4: Brazil generics market value: $ million, 2015–19
Table 5: Brazil generics market volume: % of total pharma, 2015–19
Table 6: Brazil generics market geography segmentation: $ million, 2019
Table 7: Brazil generics market value forecast: $ million, 2019–24
Table 8: Brazil generics market volume forecast: % of total pharma, 2019–24
Table 9: Brazil size of population (million), 2015–19
Table 10: Brazil gdp (constant 2005 prices, $ billion), 2015–19
Table 11: Brazil gdp (current prices, $ billion), 2015–19
Table 12: Brazil inflation, 2015–19
Table 13: Brazil consumer price index (absolute), 2015–19
Table 14: Brazil exchange rate, 2015–19
Table 15: China generics market value: $ billion, 2015–19
Table 16: China generics market volume: % of total pharma, 2015–19
Table 17: China generics market geography segmentation: $ billion, 2019
Table 18: China generics market value forecast: $ billion, 2019–24
Table 19: China generics market volume forecast: % of total pharma, 2019–24
Table 20: China size of population (million), 2015–19
Table 21: China gdp (constant 2005 prices, $ billion), 2015–19
Table 22: China gdp (current prices, $ billion), 2015–19
Table 23: China inflation, 2015–19
Table 24: China consumer price index (absolute), 2015–19
Table 25: China exchange rate, 2015–19
Table 26: India generics market value: $ billion, 2015–19
Table 27: India generics market volume: % of total pharma, 2015–19
Table 28: India generics market geography segmentation: $ billion, 2019
Table 29: India generics market value forecast: $ billion, 2019–24
Table 30: India generics market volume forecast: % of total pharma, 2019–24
Table 31: India size of population (million), 2015–19
Table 32: India gdp (constant 2005 prices, $ billion), 2015–19
Table 33: India gdp (current prices, $ billion), 2015–19
Table 34: India inflation, 2015–19
Table 35: India consumer price index (absolute), 2015–19
Table 36: India exchange rate, 2015–19
Table 37: Russia generics market value: $ billion, 2015–19
Table 38: Russia generics market volume: % of total pharma, 2015–19
Table 39: Russia generics market geography segmentation: $ billion, 2019
Table 40: Russia generics market value forecast: $ billion, 2019–24
Table 41: Russia generics market volume forecast: % of total pharma, 2019–24
Table 42: Russia size of population (million), 2015–19
Table 43: Russia gdp (constant 2005 prices, $ billion), 2015–19
Table 44: Russia gdp (current prices, $ billion), 2015–19
Table 45: Russia inflation, 2015–19
Table 46: Russia consumer price index (absolute), 2015–19
Table 47: Russia exchange rate, 2015–19
Table 48: Sanofi SA: key facts
Table 49: Sanofi SA: Annual Financial Ratios
Table 50: Sanofi SA: Key Employees
LIST OF FIGURES
Figure 1: BRIC generics industry, revenue($m), 2015-24
Figure 2: BRIC generics industry, revenue($m), 2015-19
Figure 3: BRIC generics industry, revenue($m), 2019-24
Figure 4: Brazil generics market value: $ million, 2015–19
Figure 5: Brazil generics market volume: % of total pharma, 2015–19
Figure 6: Brazil generics market geography segmentation: % share, by value, 2019
Figure 7: Brazil generics market value forecast: $ million, 2019–24
Figure 8: Brazil generics market volume forecast: % of total pharma, 2019–24
Figure 9: Forces driving competition in the generics market in Brazil, 2019
Figure 10: Drivers of buyer power in the generics market in Brazil, 2019
Figure 11: Drivers of supplier power in the generics market in Brazil, 2019
Figure 12: Factors influencing the likelihood of new entrants in the generics market in Brazil, 2019
Figure 13: Factors influencing the threat of substitutes in the generics market in Brazil, 2019
Figure 14: Drivers of degree of rivalry in the generics market in Brazil, 2019
Figure 15: China generics market value: $ billion, 2015–19
Figure 16: China generics market volume: % of total pharma, 2015–19
Figure 17: China generics market geography segmentation: % share, by value, 2019
Figure 18: China generics market value forecast: $ billion, 2019–24
Figure 19: China generics market volume forecast: % of total pharma, 2019–24
Figure 20: Forces driving competition in the generics market in China, 2019
Figure 21: Drivers of buyer power in the generics market in China, 2019
Figure 22: Drivers of supplier power in the generics market in China, 2019
Figure 23: Factors influencing the likelihood of new entrants in the generics market in China, 2019
Figure 24: Factors influencing the threat of substitutes in the generics market in China, 2019
Figure 25: Drivers of degree of rivalry in the generics market in China, 2019
Figure 26: India generics market value: $ billion, 2015–19
Figure 27: India generics market volume: % of total pharma, 2015–19
Figure 28: India generics market geography segmentation: % share, by value, 2019
Figure 29: India generics market value forecast: $ billion, 2019–24
Figure 30: India generics market volume forecast: % of total pharma, 2019–24
Figure 31: Forces driving competition in the generics market in India, 2019
Figure 32: Drivers of buyer power in the generics market in India, 2019
Figure 33: Drivers of supplier power in the generics market in India, 2019
Figure 34: Factors influencing the likelihood of new entrants in the generics market in India, 2019
Figure 35: Factors influencing the threat of substitutes in the generics market in India, 2019
Figure 36: Drivers of degree of rivalry in the generics market in India, 2019
Figure 37: Russia generics market value: $ billion, 2015–19
Figure 38: Russia generics market volume: % of total pharma, 2015–19
Figure 39: Russia generics market geography segmentation: % share, by value, 2019
Figure 40: Russia generics market value forecast: $ billion, 2019–24
Figure 41: Russia generics market volume forecast: % of total pharma, 2019–24
Figure 42: Forces driving competition in the generics market in Russia, 2019
Figure 43: Drivers of buyer power in the generics market in Russia, 2019
Figure 44: Drivers of supplier power in the generics market in Russia, 2019
Figure 45: Factors influencing the likelihood of new entrants in the generics market in Russia, 2019
Figure 46: Factors influencing the threat of substitutes in the generics market in Russia, 2019
Figure 47: Drivers of degree of rivalry in the generics market in Russia, 2019
Figure 1: BRIC generics industry, revenue($m), 2015-24
Figure 2: BRIC generics industry, revenue($m), 2015-19
Figure 3: BRIC generics industry, revenue($m), 2019-24
Figure 4: Brazil generics market value: $ million, 2015–19
Figure 5: Brazil generics market volume: % of total pharma, 2015–19
Figure 6: Brazil generics market geography segmentation: % share, by value, 2019
Figure 7: Brazil generics market value forecast: $ million, 2019–24
Figure 8: Brazil generics market volume forecast: % of total pharma, 2019–24
Figure 9: Forces driving competition in the generics market in Brazil, 2019
Figure 10: Drivers of buyer power in the generics market in Brazil, 2019
Figure 11: Drivers of supplier power in the generics market in Brazil, 2019
Figure 12: Factors influencing the likelihood of new entrants in the generics market in Brazil, 2019
Figure 13: Factors influencing the threat of substitutes in the generics market in Brazil, 2019
Figure 14: Drivers of degree of rivalry in the generics market in Brazil, 2019
Figure 15: China generics market value: $ billion, 2015–19
Figure 16: China generics market volume: % of total pharma, 2015–19
Figure 17: China generics market geography segmentation: % share, by value, 2019
Figure 18: China generics market value forecast: $ billion, 2019–24
Figure 19: China generics market volume forecast: % of total pharma, 2019–24
Figure 20: Forces driving competition in the generics market in China, 2019
Figure 21: Drivers of buyer power in the generics market in China, 2019
Figure 22: Drivers of supplier power in the generics market in China, 2019
Figure 23: Factors influencing the likelihood of new entrants in the generics market in China, 2019
Figure 24: Factors influencing the threat of substitutes in the generics market in China, 2019
Figure 25: Drivers of degree of rivalry in the generics market in China, 2019
Figure 26: India generics market value: $ billion, 2015–19
Figure 27: India generics market volume: % of total pharma, 2015–19
Figure 28: India generics market geography segmentation: % share, by value, 2019
Figure 29: India generics market value forecast: $ billion, 2019–24
Figure 30: India generics market volume forecast: % of total pharma, 2019–24
Figure 31: Forces driving competition in the generics market in India, 2019
Figure 32: Drivers of buyer power in the generics market in India, 2019
Figure 33: Drivers of supplier power in the generics market in India, 2019
Figure 34: Factors influencing the likelihood of new entrants in the generics market in India, 2019
Figure 35: Factors influencing the threat of substitutes in the generics market in India, 2019
Figure 36: Drivers of degree of rivalry in the generics market in India, 2019
Figure 37: Russia generics market value: $ billion, 2015–19
Figure 38: Russia generics market volume: % of total pharma, 2015–19
Figure 39: Russia generics market geography segmentation: % share, by value, 2019
Figure 40: Russia generics market value forecast: $ billion, 2019–24
Figure 41: Russia generics market volume forecast: % of total pharma, 2019–24
Figure 42: Forces driving competition in the generics market in Russia, 2019
Figure 43: Drivers of buyer power in the generics market in Russia, 2019
Figure 44: Drivers of supplier power in the generics market in Russia, 2019
Figure 45: Factors influencing the likelihood of new entrants in the generics market in Russia, 2019
Figure 46: Factors influencing the threat of substitutes in the generics market in Russia, 2019
Figure 47: Drivers of degree of rivalry in the generics market in Russia, 2019
